- Malignant pleural mesothelioma
- Lung stereotactic body radiotherapy
Int J Radiat Oncol Biol Phys. 2019 Sep 27;:
Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy.
Oral Oncol. 2019 Oct;97:124-130
Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
Mol Carcinog. 2019 Jul 29;:
Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Eur J Cancer. 2019 Jul 19;118:112-120
Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.
Radiother Oncol. 2019 May;134:10-16
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys. 2019 Apr 04;:
J Thorac Dis. 2018 Nov;10(Suppl 33):S4088-S4092
Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
Oncologist. 2018 Nov 26;:
A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy.
Radiother Oncol. 2018 Sep 29;:
Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre